ProPhase Labs shares are trading lower by 47% during Friday's session. The company announced a 4.17 million share offering at 72 cents per share, totaling $3 million. ProPhase Labs Inc PRPH shares ...

GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and ...

在2024年第三季度财报电话会议上，Prophase Labs, Inc. (Nasdaq: PRPH) 首席执行官Ted Karkus全面介绍了公司的战略计划，重点关注即将推出的DNA Complete和DNA Expand产品、PMI的积极扩张以及成本削减计划。公司还在为即将进行的融资做准备，以支持这些计划。 Karkus强调了公司多样化的产品组合和强劲的市场需求，特别突出了食道癌检测的巨大潜 ...

ProPhase anticipates significant sequential improvement in revenues and EBITDA in Q4 2024, and beyond, driven by strategic advancements across its subsidiaries. The company remains financially ...

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare ...

On behalf of our team, we'd like to thank everyone for joining us today for the presentation of ProPhase Labs for the Third Quarter 2024 Results. ProPhase is trading on the NASDAQ under the ticker ...

04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced the launch of ...

GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and ...

Mitosis is conventionally divided into five stages known as prophase, prometaphase, metaphase, anaphase, and telophase. While mitosis is taking place, there is no cell growth and all of the ...

Prophase Labs ( (PRPH) ) has released its Q3 earnings. Here is a breakdown of the information Prophase Labs presented to its investors.

GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the "Company” or "ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced the ...

Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 Strategic Partnership Discussions Begin for BE-Smart Esophageal Cancer ...